Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Invasive Monitoring of End-Stage Renal Disease Subjects Using Alio Medical Remote Monitoring System (RMS)

NCT05382663 is registered in ClinicalTrials.gov with Alio, Inc. as lead sponsor.

NCT NCT05382663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05382663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Invasive Monitoring of End-Stage Renal Disease Subjects Using Alio Medical Remote Monitoring System (RMS)
Lead sponsor
Alio, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
March 21, 2022
Completion date
November 1, 2024
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease